Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

anti-Human Olig3, Biotin, Polyclonal, R&D Systems™

Goat Polyclonal Antibody

Supplier:  R&D Systems BAF2356

Catalog No. BAF2356

This item is not returnable. View return policy

Description

Description

Host Species: Goat
Species Reactivity:Human
Immunogen:E. coli-derived recombinant human Olig3, Met1-Lys272, Accession No. Q7RTU3

Applications:

Immunohistochemistry, Western Blotting

Specifications

Specifications

Olig3
Polyclonal
Biotin
Q7RTU3
OLIG3
E. coli-derived recombinant human Olig3 Met1-Lys272 Accession # Q7RTU3
50 μg
Primary
Detects human Olig3 in Western blots. In Western blots, less than 1% cross-reactivity with recombinant human (rh) Olig1 and rhOlig2 is observed.
Human
IgG
Western Blot, Immunohistochemistry
LYOPH
Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL
Bhlhb7, BHLHE20, bHLHe20oligo3, Class B basic helix-loop-helix protein 7, Class E basic helix-loop-helix protein 20, Oligo3, oligodendrocyte transcription factor 3
Goat
Affinity Purified
RUO
167826
Reconstitute at 0.2 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.